1. Home
  2. RDHL vs QTI Comparison

RDHL vs QTI Comparison

Compare RDHL & QTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • QTI
  • Stock Information
  • Founded
  • RDHL 2009
  • QTI 2012
  • Country
  • RDHL Israel
  • QTI United States
  • Employees
  • RDHL N/A
  • QTI 3
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • QTI
  • Sector
  • RDHL Health Care
  • QTI
  • Exchange
  • RDHL Nasdaq
  • QTI NYSE
  • Market Cap
  • RDHL 7.5M
  • QTI 10.2M
  • IPO Year
  • RDHL N/A
  • QTI N/A
  • Fundamental
  • Price
  • RDHL $5.64
  • QTI $0.47
  • Analyst Decision
  • RDHL
  • QTI
  • Analyst Count
  • RDHL 0
  • QTI 0
  • Target Price
  • RDHL N/A
  • QTI N/A
  • AVG Volume (30 Days)
  • RDHL 13.8K
  • QTI 357.3K
  • Earning Date
  • RDHL 08-29-2024
  • QTI 02-26-2025
  • Dividend Yield
  • RDHL N/A
  • QTI N/A
  • EPS Growth
  • RDHL N/A
  • QTI N/A
  • EPS
  • RDHL N/A
  • QTI N/A
  • Revenue
  • RDHL $3,707,000.00
  • QTI $4,037,118.00
  • Revenue This Year
  • RDHL $224.90
  • QTI N/A
  • Revenue Next Year
  • RDHL $82.69
  • QTI N/A
  • P/E Ratio
  • RDHL N/A
  • QTI N/A
  • Revenue Growth
  • RDHL N/A
  • QTI 10884.16
  • 52 Week Low
  • RDHL $5.41
  • QTI $0.35
  • 52 Week High
  • RDHL $31.50
  • QTI $14.40
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 35.38
  • QTI 49.47
  • Support Level
  • RDHL $5.41
  • QTI $0.40
  • Resistance Level
  • RDHL $5.79
  • QTI $0.56
  • Average True Range (ATR)
  • RDHL 0.31
  • QTI 0.07
  • MACD
  • RDHL -0.05
  • QTI 0.01
  • Stochastic Oscillator
  • RDHL 14.26
  • QTI 55.20

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About QTI QT IMAGING HOLDINGS INC

QT Imaging Holdings Inc is engaged in the research, development and commercialization of an automated breast imaging system producing high-resolution transmission ultrasound images.

Share on Social Networks: